Abstract
A 57-year-old woman was admitted with symmetrical proximal muscle weakness, liver dysfunction, abnormal muscle enzymes, and she was an antibody to hepatitis B e (anti-HBe) positive hepatitis B virus (HBV) carrier. Biopsy of her left quadriceps femoris showed myositis, so prednisolone was started at 40 mg/day. However, her hepatic function deteriorated and liver biopsy after 4 months showed acute hepatitis with partial submassive necrosis. Treatment with interferon-alpha and cyclosporin A progressively reduced the transaminase and HBV-DNA levels. Early treatment with interferon-alpha plus cyclosporin A can control exacerbation of hepatitis B.
MeSH terms
-
Alanine Transaminase / blood
-
Anti-Inflammatory Agents / administration & dosage
-
Aspartate Aminotransferases / blood
-
Cyclosporine / administration & dosage
-
DNA, Viral / blood
-
Female
-
Hepatitis B / etiology*
-
Hepatitis B / therapy*
-
Hepatitis B / virology
-
Hepatitis B Antibodies / biosynthesis*
-
Hepatitis B virus / isolation & purification
-
Humans
-
Interferon-alpha / administration & dosage
-
Liver / pathology
-
Liver Failure, Acute / etiology
-
Liver Failure, Acute / therapy
-
Liver Failure, Acute / virology
-
Middle Aged
-
Necrosis
-
Polymyositis / drug therapy*
-
Prednisolone / administration & dosage*
Substances
-
Anti-Inflammatory Agents
-
DNA, Viral
-
Hepatitis B Antibodies
-
Interferon-alpha
-
Cyclosporine
-
Prednisolone
-
Aspartate Aminotransferases
-
Alanine Transaminase